-
This pharmaceutical company focusing on rare diseases sprints to the Hong Kong Stock Exchange and has already launched products on the market
Time of Update: 2022-04-15
According to the data, Condini Pharmaceuticals is a company focused on the development, manufacture and distribution of drugs for the treatment of organ fibrosis and other rare and critical diseases .
-
[Live] From exploration to landing - CAD detectors help the pharmaceutical industry to provide multi-faceted solutions
Time of Update: 2022-04-15
How to effectively solve various problems in the process of pharmaceutical R&D and production, and explore and practice the development path of biopharmaceutical compliance has become the concern and urgent problem of the whole industry .
-
In order to accelerate the research and development of innovative drugs, the pharmaceutical company plans to raise nearly 4 billion!
Time of Update: 2022-04-15
Public information shows that since 2015, Junshi Bio has completed multiple rounds of financing in the three capital markets of the New Third Board, A shares and Hong Kong shares .
835 billion yuan; on January 4, 2019, the company over-allotted 23,836,500 H shares at an issue price of HK$19.
-
[Live] In "Extraordinary Times", how can manufacturing companies free their hands and improve their safety management level?
Time of Update: 2022-04-15
In order to help safety and ensure production, at 14:00 on April 7, 2022, Beijing Carnival Industry will bring the theme "Manufacturing in "Extraordinary Times", full-stack AR head-mounted computer remote collaboration solution to help enterprises in normal production and operation" The wonderful live broadcast will help enterprises to free their hands and improve the level of safety management.
-
scRNA-seq - providing new ideas for drug discovery
Time of Update: 2022-03-09
When using bulk RNA-seq, per-cell transcriptome differences are also masked by the averaged information across multiple cells, whereas if each cell is analyzed at the single-cell level, we can obtain information about heterogeneity, which in turn Cells can be more accurately grouped, new cell types can be discovered, expression of random genes can be studied, and cell lineage pathways can be explored .
-
WuXi Biologics was included in the "unverified list" by the United States, the company responded
Time of Update: 2022-03-09
S. Department of Commerce for the past 10 years .
S. Department of Commerce for the past 10 years .
S. Department of Commerce for the past 10 years .
-
CSPC's anti-tumor nano-drug "SYHA1908 for injection" was approved for clinical trials
Time of Update: 2022-03-08
This product is a drug independently developed by the Group using human albumin as a carrier to achieve effective delivery of a new generation of taxanes in vivo .
Therefore, this compound can improve the clinical limitations of existing taxanes that cannot achieve higher dose administration due to dose-limiting toxicity .
-
Positive preliminary clinical results of Beihai Kangcheng complement inhibitor
Time of Update: 2022-03-08
Recently, Beihai Kangcheng announced that its long-acting recombinant humanized monoclonal antibody CAN106 targeting complement protein C5 has achieved positive top-line results in a single-dose-ascending (SAD) Phase 1 clinical trial .
-
Innovative drugs: the macrocyclic structure is not only a breakthrough patent, but also a problem-solving
Time of Update: 2022-03-08
? Activity example In the development process of BACE inhibitor, some researchers have studied and analyzed the protein, and designed a macrocyclic ring structure based on this, and the activity has been significantly improved, as shown in the figure below .
-
No more side effects and no different side effects!
Time of Update: 2022-03-08
Researchers at Fox Chase Cancer Center tracked short-term side effects in 1,753 patients who received Pfizer's bt162b2 Covid-19 vaccine and found that patients who received active cancer treatment (surgery, chemotherapy, immunotherapy or radiation therapy) or had completed treatment did not develop Additional responses .
-
New Era Pharmaceuticals Fasudil Hydrochloride Injection Passes Consistency Evaluation
Time of Update: 2022-03-08
Review of Fasudil Injection Source: Minet Consistency Evaluation Database Including Shandong New Times, there are currently 8 companies whose fasudil hydrochloride injection has passed the consistency evaluation, and the product has been included in the fifth batch of centralized procurement.
-
To solve "non-drugable" and "resistance", Nature summarizes the four major trends in the development of PROTAC!
Time of Update: 2022-03-08
The authors propose that the next milestones in the PROTAC field will focus on the following four areas, namely, identifying the best protein degradation targets; expanding the scope of clinical application of E3 ligases; expanding the scope of clinical treatment to diseases beyond oncology; Develop other PROTAC modes .
-
The 8MW2311 immune agonist of Maiwei Bio-Injection was approved for clinical use
Time of Update: 2022-03-07
1. Basic information of drugs Drug name: 8MW2311 for injection Application matters: Registration clinical trial acceptance number of domestically produced drugs: CXSL2200091 National applicant: Maiwei (Shanghai) Biotechnology Co.
After entering clinical trials, the company will explore the therapeutic value of 8MW2311 for injection in advanced malignant tumors .
-
Corning Jereh PD-L1/OX40 Dual Antibody KN052 Approved for Clinical Research
Time of Update: 2022-03-07
Based on this approval, Corning Jereh will conduct a Phase Ia/Ib clinical study of KN052 in the treatment of advanced solid tumors to evaluate the efficacy of the drug.
-
Anti-solid tumor "black technology" - global R&D panorama of TIL therapy
Time of Update: 2022-03-07
Immune checkpoint inhibitors (PD-1/L1) Tumor vaccines (provenge, cimavax) Adoptive immune cell therapy (CAR-T): By collecting human autoimmune cells and culturing them in vitro, the number is expanded thousands of times , or increase the targeted killing function, and then return it to the patient to kill pathogens, cancer cells, and mutated cells in the blood and tissues .
-
Advancing the research and development of pet drugs, looking forward to Kangchen Pharmaceutical to create a Chinese version of the Pfizer model
Time of Update: 2022-03-07
This article will interpret the significance of domestic pharmaceutical companies advancing pet drug research and development from the perspectives of strategic value and market space .
-
Science published a paper revealing the rapid spread and immune escape of Omicron and the molecular mechanism of JMB2002 inhibition of Omicron
Time of Update: 2022-03-07
This study analyzed the high-resolution cryo-EM structure of the complex of Omicron spike protein and human receptor ACE2 or broad-spectrum anti-COVID-19 antibody JMB2002, explained the molecular mechanism of rapid spread and immune escape of Omicron mutants, and revealed the therapeutic antibody JMB2002 The new mechanism of action provides a theoretical basis for JMB2002 to still have the neutralizing function of the new coronavirus Omicron variant and to carry out further clinical trials .
-
The highly accessible lyophilized mRNA-LNP new crown vaccine shows good stability and immunogenicity in preclinical studies
Time of Update: 2022-03-06
Ruike Biotech has developed a freeze-dried dosage form of mRNA-LNP new crown vaccine through its subsidiary Ruikeji Biological, which will well meet such needs .
Ruikeji Bio is a biotechnology company with the world's leading mRNA vaccine platform technology and novel adjuvant technology .
-
Medtronic invests hundreds of millions of yuan in Lingang import leader to accelerate localization
Time of Update: 2022-03-06
As one of the first imported medical device companies to enter China, Medtronic has previously proposed a strategy of "increasing localization" .
As one of the first imported medical device companies to enter China, Medtronic has previously proposed a strategy of "increasing localization" .
-
Talking about drug co-crystal technology - providing solutions for poorly soluble drugs
Time of Update: 2022-03-06
PART. 01 Overview Oral administration is a common, popular, painless and easy-to-operate mode of administration . Among oral dosage forms, solid dosage forms are the most used . The solid dosage f
